Skip to content
10-Q

Quarterly Report

ONYX PHARMACEUTICALS INC

0001104659-12-073762

← back to feed
Filed
Nov 2, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Oct 31, 2012 67.15M sh
Shares Diluted Q3 2012 · Sep 30, 2012 68.46M sh
Shares Diluted Q3 2012 · Sep 30, 2012 64.36M sh
Shares Diluted Q3 2012 · Sep 30, 2011 63.56M sh
Shares Diluted Q3 2012 · Sep 30, 2011 63.33M sh
Stock Repurchased Q3 2012 · Sep 30, 2012 $124K
Stock Repurchased Q3 2012 · Sep 30, 2011 $180K
Capex Q3 2012 · Sep 30, 2012 $9.61M
Capex Q3 2012 · Sep 30, 2011 $13.96M
Cash And Equivalents Q3 2012 · Sep 30, 2012 $229.25M
Cash And Equivalents Q3 2012 · Dec 31, 2011 $171.55M
Cash And Equivalents Q3 2012 · Sep 30, 2011 $219.37M
Cash And Equivalents Q3 2012 · Dec 31, 2010 $226.34M
Stockholders Equity Q3 2012 · Sep 30, 2012 $830.64M
Stockholders Equity Q3 2012 · Dec 31, 2011 $823.41M
Current Liabilities Q3 2012 · Sep 30, 2012 $114.78M
Current Liabilities Q3 2012 · Dec 31, 2011 $111.79M
Current Assets Q3 2012 · Sep 30, 2012 $673.21M
Current Assets Q3 2012 · Dec 31, 2011 $731.85M
Total Assets Q3 2012 · Sep 30, 2012 $1.38B
Total Assets Q3 2012 · Dec 31, 2011 $1.41B
Eps Diluted Q3 2012 · Sep 30, 2012 $0.25
Eps Diluted Q3 2012 · Sep 30, 2012 −$2.25
Eps Diluted Q3 2012 · Sep 30, 2011 −$0.58
Eps Diluted Q3 2012 · Sep 30, 2011 −$2.22
Eps Basic Q3 2012 · Sep 30, 2012 $0.26
Eps Basic Q3 2012 · Sep 30, 2012 −$2.25
Eps Basic Q3 2012 · Sep 30, 2011 −$0.58
Eps Basic Q3 2012 · Sep 30, 2011 −$2.22
Sga Expense Q3 2012 · Sep 30, 2012 $61.75M
Sga Expense Q3 2012 · Sep 30, 2012 $149.6M
Sga Expense Q3 2012 · Sep 30, 2011 $42.64M
Sga Expense Q3 2012 · Sep 30, 2011 $115.35M
Net Income Q3 2012 · Sep 30, 2012 $17.4M
Net Income Q3 2012 · Sep 30, 2012 −$144.87M
Net Income Q3 2012 · Sep 30, 2011 −$36.86M
Net Income Q3 2012 · Sep 30, 2011 −$140.57M
Operating Income Q3 2012 · Sep 30, 2012 −$72.35M
Operating Income Q3 2012 · Sep 30, 2012 −$228.88M
Operating Income Q3 2012 · Sep 30, 2011 −$32.21M
Operating Income Q3 2012 · Sep 30, 2011 −$123.33M
Cost Of Revenue Q3 2012 · Sep 30, 2012 $496K
Cost Of Revenue Q3 2012 · Sep 30, 2012 $496K
Revenue Q3 2012 · Sep 30, 2012 $89.51M
Revenue Q3 2012 · Sep 30, 2012 $234.25M
Revenue Q3 2012 · Sep 30, 2011 $75.04M
Revenue Q3 2012 · Sep 30, 2011 $210.14M